Predictors of Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Definitive Chemoradiation Followed by Consolidative Durvalumab
This journal activity provides practitioners with the knowledge for practice improvement in treating patients with non-small cell lung cancer undergoing definitive chemoradiation followed by consolidative durvalumab.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Lung Cancer/Thoracic Malignancies Science Highlights
This session highlights six of the most clinically relevant abstracts within the Lung Cancer/Thoracic Malignancies track of the 2022 ASTRO Annual Meeting Scientific Program.
Category
  • Lung Cancer
Format
  • Science Highlights
  • CME only
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non–Small Cell Lung Cancer
This journal activity provides practitioners with the knowledge to guide treatment of NSCLC.
Category
  • Lung Cancer
Format
  • CME only
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Lung - Refresher 2021
The management of non-small cell lung cancer has undergone major transformation in the last three years driven by the increasing using of immunotherapy as well as local ablative therapies in advanced stage disease.  Translation of these practices into community based setting is important as overa
Category
  • Lung Cancer
Format
  • Online SA-CME
Credits
  • 1.50 Certificate of Attendance
  • 1.50 SA-CME

Pages